Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.744,28
-0,23%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bionano Genomics Inc (BNGO) Bionano Genomics Inc (BNGO) Notizie

Bionano Genomics Inc

BNGO
0,96
0,0107 (1,13%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202414:00GLOBEBionano to Report First Quarter 2024 Financial Results and..
30/4/202422:05GLOBEBionano to Present at the RBC Capital Markets 2024 Global..
24/4/202414:00GLOBEBionano Announces Publication Showing OGM’s High Resolution..
17/4/202414:00GLOBEBionano and Diagens Sign Partnership to Commercialize the..
11/4/202414:00GLOBEBionano Announces Publication Showing that OGM Detects Over..
04/4/202419:44GLOBEBionano Announces $10 Million Registered Direct Offering..
03/4/202414:00GLOBEBionano Announces Publication Showing that OGM Identifies..
02/4/202414:00GLOBEBionano Announces 9 Poster Presentations and Introduces New..
19/3/202413:00GLOBEBionano Announces Publication of a Breast Cancer Study..
07/3/202414:00GLOBEBionano Announces Extensive Lineup of Content at American..
05/3/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202422:23EDGAR2Form 8-K - Current report
05/3/202422:01GLOBEBionano Reports Fourth Quarter and Full-Year 2023 Results..
29/2/202414:00GLOBEBionano to Present at TD Cowen’s 44th Annual Health Care..
28/2/202414:16EDGAR2Form 8-K - Current report
28/2/202414:01GLOBEBionano to Report Fourth Quarter and Year End 2023 Financial..
28/2/202414:00GLOBEBionano Announces Amendment to Debt Financing Arrangement to..
22/2/202414:00GLOBEAmerican College of Medical Genetics and Genomics Includes..
31/1/202414:00GLOBEBionano to Participate in the BTIG Snowbird MedTech, Digital..
30/1/202414:00GLOBEBionano’s Symposium 2024 Featured Presentations from its..
24/1/202414:00GLOBEBionano Announces Publication of Interim Readout from Second..
23/1/202414:00GLOBEBionano Announces Full Commercial Release of the Stratys™..
19/1/202414:00GLOBEBionano Announces the Final Speaker Lineup for 2024..
11/1/202422:01GLOBEBionano Announces Peer-Reviewed Publication from its..
10/1/202414:00GLOBEBionano Announces 2024 Symposium: Four Consecutive Days of..
08/1/202414:10EDGAR2Form 8-K - Current report
08/1/202414:00GLOBEBionano Reports Preliminary Fourth Quarter and Full-Year..
28/12/202314:00GLOBEBionano Announces Significant Upgrades to its Bionano Solve..
26/12/202314:00GLOBEBionano Announces Publication of Largest Prospective..
14/12/202314:00GLOBECancers Journal Publishes Special Issue Dedicated to OGM’s..
12/12/202314:00GLOBEBionano Laboratories Announces Publication of the Analytical..
06/12/202314:00GLOBEBionano Announces Presentations Featuring OGM Utility Across..
30/11/202314:00GLOBEStudy Shows that OGM Plays an Important Role in Efficient..
29/11/202316:04GLOBEBionano Announces Publication Demonstrating Utility of OGM..
24/11/202319:05EDGAR2Form 8-K - Current report
15/11/202306:07GLOBELeddarTech Appoints Chris Stewart as Chief Financial Officer
14/11/202314:00GLOBEBionano Announces Presentation of OGM Utility Across Key..
08/11/202322:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:02EDGAR2Form 8-K - Current report
08/11/202322:01GLOBEBionano Reports Third Quarter 2023 Results and Highlights..
07/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
02/11/202313:00GLOBEThompson and Thompson Genetics and Genomics in Medicine..
01/11/202321:05GLOBEBionano to Present at the 2023 Stifel Healthcare Conference
01/11/202313:00GLOBEBionano to Report Third Quarter 2023 Financial Results and..
26/10/202314:00GLOBEBionano Announces Presentation of OGM Utility Across Key..
Apertura: 0,9763 Min: 0,9301 Max: 1,02
Chiusura: 0,9493

La tua Cronologia

NASDAQ
BNGO
Bionano Genomics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network